Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Bode

Showing results (511-520 of 600) with videos related to

Pageof 60
Sort By:
Heart Rhythm|July 30, 2013
Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbitsKatja E Odening, Bernd A Jung, Corinna N Lang, et al.
Neurocritical Care|April 13, 2021
Correction to: Intracerebral Hemorrhage in COVID-19 Patients with Pulmonary Failure: A Propensity Score-Matched Registry StudyCorinna N Lang, Johanna S Dettinger, Michael Berchtold-Herz, et al.
American Heart Journal|October 11, 2011
Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndromeMichelle L O'Donoghue, Eugene Braunwald, Harvey D White, et al.
Circulation|April 6, 2017
P2X<sub>7</sub> Deficiency Blocks Lesional Inflammasome Activity and Ameliorates Atherosclerosis in MicePeter Stachon, Adrian Heidenreich, Julian Merz, et al.
Neurocritical Care|February 23, 2021
Intracerebral Hemorrhage in COVID-19 Patients with Pulmonary Failure: A Propensity Score-Matched Registry StudyCorinna N Lang, Johanna S Dettinger, Michael Berchtold-Herz, et al.
European Heart Journal|November 21, 2015
EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary interventionC Michael Gibson, Robert P Giugliano, Robert A Kloner, et al.
The Journal of Invasive Cardiology|November 5, 2013
Safety of very early sheath removal in patients treated with REG1 for acute coronary syndromes: insights from the RADAR trialJohn P Vavalle, Thomas J Povsic, Laura H Aberle, et al.
Circulation|April 28, 2010
Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wallAnna Missiou, Natascha Köstlin, Nerea Varo, et al.
The American Journal of Cardiology|December 4, 2018
Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis)Serge Korjian, Yazan Daaboul, François Laliberté, et al.
International Journal of Cardiology|July 19, 2018
Electro-mechanical (dys-)function in long QT syndrome type 1David Ziupa, Marius Menza, Susanne Koppermann, et al.
Pageof 60

Showing results (511-520 of 600) with videos related to

Sort By:
Pageof 60
Heart Rhythm|July 30, 2013
Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbitsKatja E Odening, Bernd A Jung, Corinna N Lang, et al.
Neurocritical Care|April 13, 2021
Correction to: Intracerebral Hemorrhage in COVID-19 Patients with Pulmonary Failure: A Propensity Score-Matched Registry StudyCorinna N Lang, Johanna S Dettinger, Michael Berchtold-Herz, et al.
American Heart Journal|October 11, 2011
Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndromeMichelle L O'Donoghue, Eugene Braunwald, Harvey D White, et al.
Circulation|April 6, 2017
P2X<sub>7</sub> Deficiency Blocks Lesional Inflammasome Activity and Ameliorates Atherosclerosis in MicePeter Stachon, Adrian Heidenreich, Julian Merz, et al.
Neurocritical Care|February 23, 2021
Intracerebral Hemorrhage in COVID-19 Patients with Pulmonary Failure: A Propensity Score-Matched Registry StudyCorinna N Lang, Johanna S Dettinger, Michael Berchtold-Herz, et al.
European Heart Journal|November 21, 2015
EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary interventionC Michael Gibson, Robert P Giugliano, Robert A Kloner, et al.
The Journal of Invasive Cardiology|November 5, 2013
Safety of very early sheath removal in patients treated with REG1 for acute coronary syndromes: insights from the RADAR trialJohn P Vavalle, Thomas J Povsic, Laura H Aberle, et al.
Circulation|April 28, 2010
Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wallAnna Missiou, Natascha Köstlin, Nerea Varo, et al.
The American Journal of Cardiology|December 4, 2018
Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis)Serge Korjian, Yazan Daaboul, François Laliberté, et al.
International Journal of Cardiology|July 19, 2018
Electro-mechanical (dys-)function in long QT syndrome type 1David Ziupa, Marius Menza, Susanne Koppermann, et al.
Pageof 60